跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPFOLDA 65 MG CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OPFOLDA 65 MG CAPSULAS DURAS
Approved
STANDARD
OPFOLDA 65 MG CAPSULAS DURAS
Amicus Therapeutics Europe Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 21, 2023
Approval ID
afa4ef86089dfc95
Company
Amicus Therapeutics Europe Limited
Type
Standard
Approval Details
Approval Id
afa4ef86089dfc95
Drug Cima Aemps Name
OPFOLDA 65 MG CAPSULAS DURAS
Register Number
1231737001
Holder Company Name
Amicus Therapeutics Europe Limited
Marketing Company Name
Amicus Therapeutics S.L.U
Holder Company Detail Path
/organization/amicus-therapeutics-europe-limited
Authorization Date
2023-07-21
Dosage Form
CÁPSULA DURA
Dose
65 MG
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Amicus Therapeutics Europe Limited
Company Detail Path
/organization/amicus-therapeutics-europe-limited
Company Information
Pharmaceutical Company Name
AMICUS THERAPEUTICS EUROPE LIMITED
Country Name
Ireland
City Name
dublin 15,country_ie
Address
BLOCK 1, BLANCHARDSTOWN CORPORATE PARK
Active Ingredients
MIGLUSTAT
65 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 21, 2023
Approval ID
afa4ef86089dfc95
Type
Standard
Back to CIMA-AEMPS Approvals